Overview
- Gesundheit Nord confirmed 34 women were overtreated after pathology at Klinikum Bremen‑Mitte misclassified tumors between October 2024 and November 2025.
- The patients received antibody therapy and, in some cases, chemotherapy that the clinic now says was not indicated, with reports of severe side effects and possible long‑term harms.
- Bremen prosecutors opened investigations on suspicion of negligent bodily harm in 34 cases, with inquiries initially not directed at a named individual.
- The pathologist was removed from the task in Bremen; Universitätsmedizin Göttingen reviewed her work there, reported no irregularities, and temporarily relieved her of duties pending quality review.
- Political leaders called for full transparency, independent checks, and stronger quality assurance, while affected hospitals instituted a four‑eyes principle for sensitive findings.